# A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

> **NCT01149811** · — · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 27 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Fipamezole ODT
- **DRUG:** Fipamezole ODT Cohort 2

## Key facts

- **NCT ID:** NCT01149811
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149811, "A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01149811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*